Clinical Trial Update: Effects of Chantix on Relapse Prevention for Smoking Cessation [Phase 4]

View source ↗

Summary

This Phase 4 study evaluates varenicline (Chantix) for relapse prevention in people attempting to quit smoking.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Drugs mentioned

• CHANTIX (varenicline tartrate)

Snippet

Sponsor: University of Pennsylvania | Conditions: Nicotine Dependence | Phase 4 | Status: COMPLETED